Cohance Lifesciences Ltd

Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the transcript of the earnings conference call for the quarter and year ended March 31 2023 conducted after the meeting of Board of Directors held on May 25 2023.The above information has been uploaded on the Companys website at https://www.suvenpharm.com/index.php/investors/financial-info/quarterly-releaseThis is for your information and record.